BioCryst Pharmaceuticals, Inc. (BCRX)
8.62
-0.28
(-3.15%)
USD |
NASDAQ |
May 08, 16:00
8.62
0.00 (0.00%)
After-Hours: 20:00
BioCryst Pharmaceuticals EPS Diluted (Quarterly) : -2.980 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.3737 |
| KalVista Pharmaceuticals, Inc. | -0.1055 |
| Revolution Medicines, Inc. | -2.291 |
| Plus Therapeutics, Inc. | -1.03 |
| Perspective Therapeutics, Inc. | -0.5043 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -721.81M |
| Revenue (Quarterly) | 156.41M |
| Total Expenses (Quarterly) | 878.22M |
| Enterprise Value | 2.810B |
| Gross Profit Margin (Quarterly) | 95.88% |
| Profit Margin (Quarterly) | -461.5% |
| Earnings Yield | -20.61% |
| Operating Earnings Yield | 16.27% |
| Normalized Earnings Yield | 3.471 |